Savara SVRA
NASDAQ SVRA
$5.16 +0.08 (+1.57%)
At close: Sep 30, 2026 · 4:00 PM EDT

Savara (SVRA) EBITDA Margin (2015 - 2020)

Updated

Savara's EBITDA Margin came in at -1294600.00% for Q4 2020, down 1290411.72 percentage points from the prior quarter.

Analysis

Savara (SVRA) EBITDA Margin (2015 - 2020) Analysis & Trends

For FY2020, Savara's EBITDA Margin was -19083.66%.

  • EBITDA Margin carries a five-year change of -8385.51 percentage points (FY2015 to FY2020).
  • Going back by year, EBITDA Margin was -2712.25% in FY2016 (+7985.90 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 35.95%
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 49.01%
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 6.02%
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 33.11%
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 46.01%
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -124.26%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 39.16%
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 39.10%
10 Savara 1.04 Bn 1.04 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 -1,294,600.00%
Sep 30, 2020 -4,188.28%
Mar 31, 2017 -5,067.02%
Dec 31, 2016 -1,007.75%
Sep 30, 2016 -7,124.44%
Dec 31, 2015 -17,912.96%
API Access

Savara EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=SVRA&period=max&api_key=YOUR_API_KEY